David Loebenberg - Publications, H-index & Citations

David Loebenberg

merck & company

35H指数

160论文数

6.6K被引数

收录论文 29

发表时间

Caryophyllenes from a Fungal Culture of Chrysosporium pilosum

JOURNAL OF NATURAL PRODUCTS

IF3.6

2009-01-30

PREAI

Yang, Shu-Wei; Chan, Tze-Ming; Terracciano, Joseph; Boehm, Eric; Patel, Reena; Chen, Guodong; Loebenberg, David; Patel, Mahesh; Gullo, Vincent; Pramanik, Birendra; Chu, Min

Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2006-07-01

OAAI

Cacciapuoti, A; Halpern, J; Mendrick, C; Norris, C; Patel, R; Loebenberg, D

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2006-06-01

424

OAAI

Sabatelli, F.; Patel, R.; Mann, P. A.; Mendrick, C. A.; Norris, C. C.; Hare, R.; Loebenberg, D.; Black, T. A.; McNicholas, P. M.

Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2005-03-01

OAAI

Carrillo-Muñoz, AJ; Quindós, G; Ruesga, M; Alonso, R; del Valle, O; Hernández-Molina, JM; McNicholas, P; Loebenberg, D; Santos, P

Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2005-02-01

OAAI

Cacciapuoti, A; Gurnani, M; Halpern, J; Norris, C; Patel, R; Loebenberg, D

Posaconazole is a potent inhibitor of sterol 14α-demethylation in yeasts and molds

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-10-01

OAAI

Munayyer, HK; Mann, PA; Chau, AS; Yarosh-Tomaine, T; Greene, JR; Hare, RS; Heimark, L; Palermo, RE; Loebenberg, D; McNicholas, PM

Antifungal activities of posaconazole and granulocyte-macrophage colon-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-10-01

OAAI

Simitsopoulou, M; Gil-Lamaignere, C; Avramidis, N; Maloukou, A; Lekkas, S; Havlova, E; Kourounaki, L; Loebenberg, D; Roilides, E

Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-08-01

OAAI

Patera, AC; Menzel, F; Jackson, C; Brieland, JK; Halpern, J; Hare, R; Cacciapuoti, A; Loebenberg, D

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-06-01

OAAI

Graybill, JR; Najvar, LK; Johnson, E; Bocanegra, R; Loebenberg, D

Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-02-01

260

OAAI

Xiao, L; Madison, V; Chau, AS; Loebenberg, D; Palermo, RE; McNicholas, PM

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-01-01

160

OAAI

Andes, D; Marchillo, K; Conklin, R; Krishna, G; Ezzet, F; Cacciapuoti, A; Loebenberg, D

Activity of posaconazole in treatment of experimental disseminated zygomycosis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2003-11-01

141

OAAI

Dannaoui, E; Meis, JFGM; Loebenberg, D; Verweij, PE

Activity of posaconazole against Pseudallescheria boydii:: In vitro and in vivo assays

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2003-04-01

OAAI

González, GM; Tijerina, R; Najvar, LK; Bocanegra, R; Rinaldi, MG; Loebenberg, D; Graybill, JR

Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome p450 14α-demethylase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2003-02-01

179

OAAI

Mann, PA; Parmegiani, RM; Wei, SQ; Mendrick, CA; Li, X; Loebenberg, D; DiDomenico, B; Hare, RS; Walker, SS; McNicholas, PA

ISOBENZOFURANS AS CONFORMATIONALLY CONSTRAINED MICONAZOLE ANALOGS WITH IMPROVED ANTIFUNGAL POTENCY

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2002-05-01

PREAI

LOVEY, RG; ELLIOTT, AJ; KAMINSKI, JJ; LOEBENBERG, D; PARMEGIANI, RM; RANE, DF; GIRIJAVALLABHAN, VM; PIKE, RE; GUZIK, H; ANTONACCI, B; TOMAINE, TY

In vitro and in vivo activities of posaconazole against Coccidioides immitis

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2002-05-01

OAAI

González, GM; Tijerina, R; Najvar, LK; Bocanegra, R; Rinaldi, M; Loebenberg, D; Graybill, JR

Susceptibility of pneumococci to evernimicin:: effect of CO2 and different methodologies

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2001-06-01

OAAI

Hamilton-Miller, JMT; Shah, S; Loebenberg, D

In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophages

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2001-03-01

OAAI

Zbaida, S; Brieland, J; Krieter, P; Loebenberg, D; Krishna, G; Horne, D; Lu, XW; Yuan, Y; Hare, R; Cayen, MN; Patrick, JE

Evernimicin (SCH27899) inhibits a novel ribosome target site: Analysis of 23S ribosomal DNA mutants

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2000-11-01

OAAI

Adrian, PV; Mendrick, C; Loebenberg, D; McNicholas, P; Shaw, KJ; Klugman, KP; Hare, RS; Black, TA

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2000-10-01

OAAI

Connolly, P; Wheat, LJ; Schnizlein-Bick, C; Durkin, M; Kohler, S; Smedema, M; Goldberg, J; Brizendine, E; Loebenberg, D

研究方向